So let's assume that not every investor and market participant has an engineering degree, an MBA, or IT related degree and industry experience..
Is it fair to say that there comes a point where you explain to the market the benefits the Akida IP integration into the ARM Cortex M85, not just that it integrates? Would it not warrant more than one sentence if it is indeed groundbreaking?
Investors can only assume that it isn't a big deal, because it comes with zero expansion of definition or specifics on the likely potential impact to both ARM and Brainchip.
And on NDA's, BRN is named, ARM is named and the use case is named. Therefore what is there to keep a secret?
Why is it assumed information how big or small a deal this is? Why can't they at least discuss the market for that product in some detail? It just doesn't give you any confidence in the company from my view.
Shareman, TD et al are innocent on all counts until the company proves otherwise IMO.
IMO
- Forums
- ASX - By Stock
- Ann: Appendix 4C and Quarterly Activities Report
BRN
brainchip holdings ltd
Add to My Watchlist
0.00%
!
20.5¢

So let's assume that not every investor and market participant...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $415.2M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $1.208M | 5.898M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
52 | 2248810 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 369721 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 1850019 | 0.200 |
26 | 1277507 | 0.195 |
56 | 1841112 | 0.190 |
40 | 1366842 | 0.185 |
65 | 1233007 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 257259 | 3 |
0.210 | 978887 | 19 |
0.215 | 1370152 | 18 |
0.220 | 2146303 | 50 |
0.225 | 741889 | 12 |
Last trade - 16.13pm 04/07/2025 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online